Table 4. Outcome of PTCL Categories... | American Society of Hematology

Table 4.

Outcome of PTCL Categories Compared With BCL Patients

Histology	Cell Type	n	CR (%)	P Value	5-yr OS (%)	P Value
BCL	B	1,595	63	.005	53	.0004
PTCL	T	288	54		41
All other non-ALCL	T	228	49	.002	35	.0001
Anaplastic	T	60	72		64
Large cell	B	1,390	62	.02	52	.0005
PML	T	145	53		37
Diffuse mixed	B	79	43	.9	46	.003
AIL, LE	T	83	42		31
AIL, LE	T	83	42	.1	31	.7
PML	T	145	53		37
IPI score^3-150
0 factors	B	216	81	.7	84	.1
	T	35	82		77
1 factor	B	319	71	.7	63	.7
	T	45	73		60
2 factors	B	359	63	.4	53	.01
	T	63	58		36
3 factors	B	539	52	.001	35	.03
	T	118	35		23

Histology	Cell Type	n	CR (%)	P Value	5-yr OS (%)	P Value
BCL	B	1,595	63	.005	53	.0004
PTCL	T	288	54		41
All other non-ALCL	T	228	49	.002	35	.0001
Anaplastic	T	60	72		64
Large cell	B	1,390	62	.02	52	.0005
PML	T	145	53		37
Diffuse mixed	B	79	43	.9	46	.003
AIL, LE	T	83	42		31
AIL, LE	T	83	42	.1	31	.7
PML	T	145	53		37
IPI score^3-150
0 factors	B	216	81	.7	84	.1
	T	35	82		77
1 factor	B	319	71	.7	63	.7
	T	45	73		60
2 factors	B	359	63	.4	53	.01
	T	63	58		36
3 factors	B	539	52	.001	35	.03
	T	118	35		23

Abbreviation: LE, lymphoepithelioid.

Based on data from 261 PTCL and 1,433 BCL patients.